针对重症监护单位获得的弱点的生物标志物:用于预测,诊断和预后的系统性审查
Jiamei Song1,2, Ting Deng1,2, Qingmei Yu1,2
1Nursing Department, Affiliated Hospital of Zunyi Medical University, No. 149, Dalian Road, Huichuan District, Zunyi City, 563000, Guizhou Province, China.
Annals of intensive care
|July 2, 2025
概括
生物标志物对诊断和预测重症监护室获得的弱点 (ICU-AW) 在重症患者中显示出希望. 增长差异化因子-15显示出极好的效用,但需要进一步验证以获得临床应用.
科学领域:
- 临界护理医学 临界护理医学
- 生物标志物发现发现
- 神经肌肉疾病 神经肌肉疾病
背景情况:
- 在重症监护室获得的虚弱 (ICU-AW) 是一种常见的并发症,影响患者的治疗结果.
- 目前ICU-AW的诊断方法在接受和应用方面受到限制.
- 生物标志物为改善ICU-AW评估提供了潜力.
研究的目的:
- 系统地审查和综合关于ICU-AW诊断,预测和预后生物标志物的证据.
- 评估已识别的生物标志物的诊断和预测准确性.
- 为了确定有前途的生物标志物,以实现未来的临床实用性.
主要方法:
- 在多个数据库 (PubMed,Embase等) 进行系统的文献搜索. 在2025年1月之前.
- 使用纽卡斯尔-太华和QUADAS-2工具进行包含研究的质量评估.
- 提取生物标记特征,诊断标准和结果的数据.
主要成果:
- 涉及1176名患者的11项研究确定了10个潜在的ICU-AW生物标志物.
- 六个生物标志物显示出很强的准确性 (AUC>0.80),其中GDF-15显示出极好的效用性 (AUC ≥0.85).
- 四个生物标志物表现出中等准确度 (AUC 0.60-0.80).
结论:
- 十个生物标志物显示出ICU-AW评估的潜力,但临床效用是可变的.
- 大规模的前性研究对于验证至关重要.
- 先进的技术可以改进现有的生物标志物,并识别新的生物标志物.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
352
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
352
Myasthenia Gravis: Diagnostic Tests
1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
59
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
59


